Neurology Central

Neuroblastoma detected by novel biomarker assay with increased sensitivity

0
New research from The Saban Research Institute of Children’s Hospital Los Angeles (CHLA) (CA, US), has resulted in the development and testing of a novel biomarker that detects the presence of neuroblastoma as well as quantifying disease, even in cases where standard evaluations yield negative results.
To view restricted content, please:
Share:

Leave A Comment